Skip to Main Content

Recombinant human interleukin-2

OptiLeukin™ 2

Product Number 777OLK108 / 777OLK107
Form Liquid, Closed-System
Origin Animal-Origin Free
Status GMP

GMP Recombinant human interleukin-2 for T-cell, Treg, TIL, NK, and γδ T-cell expansion across research, process development, and cGMP cell therapy manufacturing.

OptionPrice
Closed-System Liquid (100k IU)Contact Product Applications
Liquid Vial (1M IU)Contact Product Applications
Lyophilized Powder Vial (100 μg)Contact Product Applications

Please contact the Product Applications Team at info@invitria.com

Composition

Purity
≥97%
Endotoxin
≤0.01 EU/µg
Activity (ED50)
Determined by proliferation of mouse CTLL-2 cells
Formats
Liquid, closed-system

Compliance

Manufacturing
cGMP, ISO 9001:2015
Facility
Junction City, KS
Sterility
Sterile Liquid
Documentation
Lot-specific CoA
View complete specifications

Product overview

A recombinant IL-2 for immune cell expansion.

OptiLeukin™ 2 is recombinant human interleukin-2 for CAR-T, TIL, NK, Treg, and γδ T-cell expansion, from research through cGMP manufacturing. Whether your process calls for a powder, a ready-to-use liquid, or a fully closed system, there is a format to match. The lyophilized powder (555OLK0070) lets you reconstitute at the concentration your protocol requires, a flexible fit for research and process development. The liquid vial (777OLK108) arrives ready to use, removing the reconstitution step.

For closed manufacturing, the cGMP closed-system liquid (777OLK107) is designed to be welded directly into your process. That eliminates IL-2 and media syringe preparation under Grade A conditions and lets IL-2 be added directly in Grade C/D environments. With no lyophilized material to reconstitute and no open handling steps, contamination risk is reduced and the process becomes more robust. IL-2 can be delivered throughout the culture, the container evacuates completely so no material is left behind, and operators have fewer steps to manage.

Featured Resources

The published data behind the claims

Technical specifications

Attribute Value
Physical & Chemical
Form Liquid
Molecular weight ~15.5 kDa
Purity ≥97%
Endotoxin level ≤0.01 EU/µg
Activity (ED50) ED50 ≤1 ng/mL as determined by proliferation of mouse CTLL-2 cells
Size/Amount 100,000 IU (closed-system liquid), 1M IU (liquid vial), 100 µg (lyophilized vial)
Sterility Sterile Liquid
Shelf life 9 months from DOM (liquid) w/ ongoing stability study
Storage conditions 2 to 8 °C
Composition
Product name OptiLeukin™ 2
Brand InVitria®
SKU / Product Number 777OLK108 liquid vial · 777OLK107 closed-system format
Protein Recombinant Human Interleukin-2 (rhIL-2)
Class Cytokine / Interleukin
Synonyms IL-2, rhIL-2
Status Recombinant, Animal-Origin Free
Carrier protein / stabilizer None (no additives or preservatives)
Regulatory
Production standard ISO 9001:2015, cGMP-compliant facility
Country of origin USA (Junction City, KS)
Documentation Certificate of Analysis (request form) · Data Sheet · Guidelines for Use · Certificate of Origin and Animal-Free / TSE-BSE Statement · ISO 9001:2015 certificate · cGMP Statement · product-specific Technical Summary on request

Key Benefits

Low Endotoxin Specification
OptiLeukin™ 2 is released at ≤0.01 EU/µg endotoxin.
Matches a GMP Competitor IL-2
Day 10 T cell expansion matched a GMP IL-2 for two lots and two donors.
Formats for every stage
A liquid vial (777OLK108) for process development and a closed-system format (777OLK107) for closed-loop CAR-T, TIL, NK, Treg, and γδ T-cell manufacturing.
High Purity, Carrier-Free
Closed-system format: ≥97% purity, sterile, mycoplasma-negative, with no carrier protein or stabilizer.

How to order OptiLeukin™ 2

Catalog purchase
OptiLeukin 2 is supplied by quote. Both formats are quoted through the request form: the liquid vial (777OLK108) for process development, and the closed-system format (777OLK107) for cGMP manufacturing.
Purchase Order
Contact info@invitria.com or a Product Applications team member at InVitria to submit a PO directly.
Bulk pricing
Bulk and custom packaging is available to support cell therapy process development and clinical manufacturing. Working directly with InVitria gives access to bulk and commercial-scale supply, volume-tier pricing, and GMP supply commitments. Start with a bulk pricing request.
Regional distribution
OptiLeukin 2 is available worldwide through multiple purchasing pathways, including distributors through the Find a Distributor request. It is also available through Fisher Scientific, VWR, and the Labviva procurement platform. European customers can order with direct fulfillment from InVitria’s Rotterdam, Netherlands facility.

Common questions

OptiLeukin™ 2 is built for these applications